Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
This study has finished and is no longer accepting participants.
Multiple locations, including BostonTaurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder
This study ended early.
Multiple locations, including Belmont
Texting to Improve Adherence in HIV+ With Bipolar Disorder
This study has finished and is no longer accepting participants.
In San DiegoA Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In TorontoTime-Restricted Eating as an Adjunctive Intervention for Bipolar Disorder: Acceptability and Feasibility
This study ended early.
In BerkeleyTopiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting
This study has finished and is no longer accepting participants.
Location not clearly listedA Double-Blind, Randomized, Placebo-Controlled, Pilot Study of Topiramate vs. Placebo in Combination With Olanzapine for the Prevention of Weight Gain in Manic or Mixed Youth With Bipolar Disorder
This study has finished and is no longer accepting participants.
In Cincinnati
Transcranial Photobiomodulation for Executive Function in Bipolar Disorder (TPEB)
This study has finished and is no longer accepting participants.
In CharlestownResearchers compared Metformin and placebo to find out how the approaches affected depression symptoms in people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including PittsburghTreatment Adherence Enhancement in Bipolar Disorder
This study has finished and is no longer accepting participants.
In ClevelandTreatment and Outcome of Early Onset Bipolar Disorder
This study has finished and is no longer accepting participants.
In Glen OaksResearchers compared olanzapine, haloperidol and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I.
This study has finished and is no longer accepting participants.
Multiple locations, including AichiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.